Graph AI develops a pharmacovigilance platform that supports patient safety and regulatory operations across the pharmaceutical lifecycle.
Graph AI has raised $13.3M in total funding. The most recent round was Series A. The last funding was announced in September 2026.
Graph AI's investors include Insight Partners, Bessemer Venture Partners.
Graph AI is headquartered in Pleasanton, United States.
Graph AI develops a pharmacovigilance platform that supports patient safety and regulatory operations across the pharmaceutical lifecycle.
Graph AI is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Graph AI — Funding & Investors." VCBacked, September 10, 2026, https://www.vcbacked.co/company/graph-ai. Accessed October 29, 2026.
VCBacked. (2026). Graph AI — Funding & Investors. Retrieved October 29, 2026, from https://www.vcbacked.co/company/graph-ai
{{cite web |title=Graph AI — Funding & Investors |url=https://www.vcbacked.co/company/graph-ai |website=VCBacked |access-date=October 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated